Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00EJP
|
|||
| Former ID |
DNCL003603
|
|||
| Drug Name |
GSK2339345
|
|||
| Synonyms |
GSK-2339345
Click to Show/Hide
|
|||
| Indication | Cough [ICD-11: MD12; ICD-10: R05; ICD-9: 786.2] | Phase 2 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium channel unspecific (NaC) | Target Info | Modulator | [2] |
| KEGG Pathway | Dopaminergic synapse | |||
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01899768) GSK2339345 Hypertussive Challenge Study. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01494636) The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.